Anthony D. Ormerod

8.2k total citations
99 papers, 4.3k citations indexed

About

Anthony D. Ormerod is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Anthony D. Ormerod has authored 99 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Dermatology, 27 papers in Immunology and 21 papers in Epidemiology. Recurrent topics in Anthony D. Ormerod's work include Dermatology and Skin Diseases (22 papers), Psoriasis: Treatment and Pathogenesis (17 papers) and Contact Dermatitis and Allergies (17 papers). Anthony D. Ormerod is often cited by papers focused on Dermatology and Skin Diseases (22 papers), Psoriasis: Treatment and Pathogenesis (17 papers) and Contact Dermatitis and Allergies (17 papers). Anthony D. Ormerod collaborates with scholars based in United Kingdom, Australia and United States. Anthony D. Ormerod's co-authors include Catherine Smith, Nick J. Reynolds, Richard Weller, A. David Burden, C.E.M. Griffiths, Juliet N. Barker, Nigel Benjamin, A.V. Anstey, David J. Gawkrodger and Richard B. Warren and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Cochrane Database of Systematic Reviews.

In The Last Decade

Anthony D. Ormerod

96 papers receiving 4.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anthony D. Ormerod 2.0k 1.6k 728 643 636 99 4.3k
Gerald G. Krueger 2.3k 1.2× 3.5k 2.2× 694 1.0× 894 1.4× 546 0.9× 114 6.0k
J.‐P. Ortonne 1.5k 0.8× 2.0k 1.3× 360 0.5× 556 0.9× 516 0.8× 69 3.4k
Leon Kircik 2.8k 1.4× 1.4k 0.9× 583 0.8× 418 0.7× 328 0.5× 356 4.2k
Fabio Ayala 1.8k 0.9× 1.2k 0.8× 355 0.5× 549 0.9× 289 0.5× 196 3.5k
Matteo Megna 2.3k 1.1× 2.1k 1.3× 495 0.7× 416 0.6× 551 0.9× 249 4.1k
Mamitaro Ohtsuki 3.4k 1.7× 3.8k 2.3× 463 0.6× 821 1.3× 782 1.2× 186 6.8k
Lyn Guenther 1.6k 0.8× 1.5k 0.9× 533 0.7× 369 0.6× 453 0.7× 124 3.1k
Ortonne Jp 1.4k 0.7× 1.3k 0.8× 324 0.4× 437 0.7× 482 0.8× 133 3.0k
Nicola Balato 1.9k 1.0× 1.5k 0.9× 418 0.6× 482 0.7× 288 0.5× 180 3.6k
Gerald D. Weinstein 3.3k 1.6× 3.2k 2.0× 1.0k 1.4× 908 1.4× 848 1.3× 132 7.4k

Countries citing papers authored by Anthony D. Ormerod

Since Specialization
Citations

This map shows the geographic impact of Anthony D. Ormerod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony D. Ormerod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony D. Ormerod more than expected).

Fields of papers citing papers by Anthony D. Ormerod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony D. Ormerod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony D. Ormerod. The network helps show where Anthony D. Ormerod may publish in the future.

Co-authorship network of co-authors of Anthony D. Ormerod

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony D. Ormerod. A scholar is included among the top collaborators of Anthony D. Ormerod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony D. Ormerod. Anthony D. Ormerod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chu, Linda Lawson, Ivan Depasquale, et al.. (2022). TGFβ2 Induces the Soluble Isoform of CTLA-4 – Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma. Frontiers in Immunology. 12. 763877–763877. 12 indexed citations
2.
Mason, K.J., A. David Burden, Juliet N. Barker, et al.. (2021). Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR. Journal of the European Academy of Dermatology and Venereology. 35(8). e498–e501. 4 indexed citations
3.
Mason, K.J., A. David Burden, Juliet N. Barker, et al.. (2021). Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non‐biologic systemic therapies. Journal of the European Academy of Dermatology and Venereology. 35(8). e496–e498. 3 indexed citations
4.
5.
Yiu, Zenas Z N, Catherine Smith, Darren M. Ashcroft, et al.. (2017). Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). Journal of Investigative Dermatology. 138(3). 534–541. 49 indexed citations
6.
Warren, Richard B., Catherine Smith, Zenas Z N Yiu, et al.. (2015). Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). Journal of Investigative Dermatology. 135(11). 2632–2640. 276 indexed citations
7.
Coates, Laura C., William Tillett, David Chandler, et al.. (2013). The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics. Lara D. Veeken. 52(10). 1754–1757. 76 indexed citations
8.
9.
Ormerod, Anthony D., Sanjay Rajpara, & Fiona E. Craig. (2010). Basal cell carcinoma.. PubMed. 2010. 5 indexed citations
10.
Gawkrodger, David J., Anthony D. Ormerod, Lindsay Shaw, et al.. (2008). Guideline for the diagnosis and management of vitiligo. British Journal of Dermatology. 159(5). 1051–1076. 225 indexed citations
11.
Ormerod, Anthony D., et al.. (2000). Dermatitis herpetiformis effectively treated with heparin, tetracycline and nicotinamide. Clinical and Experimental Dermatology. 25(3). 204–205. 23 indexed citations
12.
Benjamin, Nigel, et al.. (1997). DEPARTMENT OF ERROR. The Lancet. 349(9067). 1776–1776. 1 indexed citations
13.
Ormerod, Anthony D., et al.. (1997). Inducible nitric oxide synthase demonstrated in allergic and irritant contact dermatitis.. Acta Dermato Venereologica. 77(6). 436–440. 38 indexed citations
14.
Yeaman, Grant R., Karin S. Froebel, George Galea, Anthony D. Ormerod, & S. J. Urbaniak. (1992). Discoid lupus erythematosus in an X-linked cytochrome-positive carrier of chronic granulomatous disease. British Journal of Dermatology. 126(1). 60–65. 17 indexed citations
15.
Ormerod, Anthony D., et al.. (1986). Terfenadine and Brompheniramine Maleate in Urticaria and Dermographism. Dermatology. 173(1). 5–8. 9 indexed citations
16.
Ormerod, Anthony D.. (1985). The Wiskott‐Aldrich Syndrome. International Journal of Dermatology. 24(1). 77–81. 3 indexed citations
17.
Ormerod, Anthony D.. (1985). The Wiskott‐Aldrich Syndrome. International Journal of Dermatology. 24(2). 77–81. 1 indexed citations
18.
Ormerod, Anthony D.. (1984). Syncope.. BMJ. 288(6425). 1219–1222. 3 indexed citations
19.
Ormerod, Anthony D.. (1984). Urticaria and angio-oedema.. BMJ. 289(6449). 903–906. 5 indexed citations
20.
Ormerod, Anthony D., et al.. (1984). Dermatitis.. BMJ. 289(6445). 605–608. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald G. Krueger Breakdown of academic impact, for papers by J.‐P. Ortonne Breakdown of academic impact, for papers by Leon Kircik Breakdown of academic impact, for papers by Fabio Ayala Breakdown of academic impact, for papers by Matteo Megna Breakdown of academic impact, for papers by Mamitaro Ohtsuki Breakdown of academic impact, for papers by Lyn Guenther Breakdown of academic impact, for papers by Ortonne Jp Breakdown of academic impact, for papers by Nicola Balato Breakdown of academic impact, for papers by Gerald D. Weinstein
Rankless by CCL
2026